Epigenetic dysregulation in cancer: mechanisms, diagnostic biomarkers and therapeutic strategies
Komal Imran(University of Sialkot), Daniela Călina(University of Medicine and Pharmacy of Craiova), Hernán Cortés(Instituto Nacional de Rehabilitación), Luca Falzone(University of Catania), Gerardo Leyva‐Gómez(Instituto Politécnico Nacional), Javad Sharifi‐Rad(Shahid Beheshti University of Medical Sciences), Octavio D. Reyes‐Hernández(Universidad Nacional Autónoma de México), Federica Longo(University of Catania), Muhammad Mushtaq Ahmed(Asian University), Gabriela Figueroa‐González(Universidad Autónoma de la Ciudad de México), Muhammad Javed Iqbal(University of Management and Technology), Ammara Khalid(Thomas Jefferson University), Massimo Libra(University of Catania)
Cited by 10
Related Papers
Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications
|Frontiers in Pharmacology|2020|944
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
|Frontiers in Pharmacology|2018|878
Antidiabetic Potential of Medicinal Plants and Their Active Components
|Biomolecules|2019|721
Thymol, thyme, and other plant sources: Health and potential uses
|Phytotherapy Research|2018|534
Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine
|Cancer Cell International|2022|454